| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700169 | 注射用重组人血清白蛋白与干扰素α-2b融合蛋白 | Lyophilized | Biological Products(1) | New Drug Application | 2018-05-15 | 山西康宝生物制品股份有限公司 | Shanxi Kangbao Biological Product Co Ltd | In Review | 2018-05-14 | view |